Prospects for adoptive T cell therapy

This publication has 45 references indexed in Scilit:

• Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.
  The Journal of Experimental Medicine, 1996
• Peptide‐specific ctl in tumor‐infiltrating lymphocytes from metastatic melanomas expressing mart‐1/melan‐a, gp100 and tyrosinase genes: A study in an unselected group of hla‐a2.1‐positive patients
  International Journal of Cancer, 1995
• In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides
  Molecular Immunology, 1995
• Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
  European Journal of Immunology, 1995
• Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2
  JNCI Journal of the National Cancer Institute, 1994
• Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation
  Nature, 1994
• A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
  The Journal of Experimental Medicine, 1993
• An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.
  The Journal of Experimental Medicine, 1993
• Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8⁺ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington
  Human Gene Therapy, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991